Stay updated on Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.

Latest updates to the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page
- CheckyesterdayChange DetectedAdded a MedlinePlus Genetics topic: Melanoma and updated the revision from v3.0.1 to v3.0.2. Removed 'Back to Top' and the old revision tag, indicating a content expansion with minor UI/metadata cleanup.SummaryDifference0.4%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new content related to skin and connective tissue diseases and various biological factors. Notably, the version has been updated to v3.0.0.SummaryDifference3%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version v2.16.10 to v2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
Stay in the know with updates to Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma Clinical Trial page.